TGFB1 and neoplasm: Having demonstrated previously that TGFβ suppresses endometrial CD8+ T cell cytotoxic killing in non-cancerous patients (17), we measured the concentration of TGFβ by ELISA to determine whether tumor secretions contain higher concentrations of TGFβ than adjacent tissue.